These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2108235)

  • 1. Protective qualities of mitochondrial and cytosolic fluorescent dyes against in vitro and in vivo infection by the Tulahuen strain of Trypanosoma cruzi.
    Dennis MV; Judy MM; Matthews JL; Sogandares-Bernal F
    J Parasitol; 1990 Apr; 76(2):171-6. PubMed ID: 2108235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural, ultrastructural studies and evolution of Trypanosoma cruzi-infected mice treated with thioridazine.
    Paglini-Oliva P; Fernández AR; Fretes R; Peslman A
    Exp Mol Pathol; 1998 Oct; 65(2):78-86. PubMed ID: 9828149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of rhodamine 123 with living cells studied by flow cytometry.
    Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
    Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of NIH 3T3 cells from infection by trypomastigotes and sphaeromastigotes of Trypanosoma cruzi, Telahuen strain, by porphyrins in the presence and absence of light (630 and 690 nm).
    Dennis MV; Judy MM; Matthews JL; Sogandares-Bernal F
    J Parasitol; 1989 Dec; 75(6):970-6. PubMed ID: 2693678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
    Barr SC; Rose D; Jaynes JM
    J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
    Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease.
    Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M
    Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice.
    Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P
    Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice.
    Arantes JM; Pedrosa ML; Martins HR; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2007 Sep; 117(1):43-50. PubMed ID: 17521632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: Cardiac mitochondrial alterations produced by different strains in the acute phase of the infection.
    Báez AL; Lo Presti MS; Rivarola HW; Pons P; Fretes R; Paglini-Oliva P
    Exp Parasitol; 2008 Dec; 120(4):397-402. PubMed ID: 18848545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction.
    Menna-Barreto RF; Goncalves RL; Costa EM; Silva RS; Pinto AV; Oliveira MF; de Castro SL
    Free Radic Biol Med; 2009 Sep; 47(5):644-53. PubMed ID: 19501647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
    Nickell SP; Stryker GA; Arevalo C
    J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.